Orexo AB develops pharmaceuticals and digital therapies addressing unmet needs within the space of substance use disorders and mental health. The products are commercialized by Orexo in the USA or via partners worldwide. The main market is the American market for buprenorphine/naloxone products, where the company commercializes its product Zubsolv for treatment of opioid use disorder. The head office, where research and development is also performed, is situated in Uppsala, Sweden.
Quote | Orexo Ab Ord (OTCMKTS:ORXOF)
Last: | $1.50 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $1.50 |
High: | $0 |
Low: | $0 |
Volume: | 4 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Orexo Ab Ord (OTCMKTS:ORXOF)
Orexo's patent win for ZUBSOLV® appealed PR Newswire UPPSALA, Sweden , July 24, 2023 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces that Sun Pharmaceutical Industries Limited, Sun Pharma Global FZE, Sun Pharma Global, Inc.,...
Orexo AB (ORXOY): Q2 GAAP EPS of -SEK2.15.Revenue of SEK142.8M (-20.3% Y/Y)Press Release For further details see: Orexo AB reports Q2 results
Message Board Posts | Orexo Ab Ord (OTCMKTS:ORXOF)
Subject | By | Source | When |
---|---|---|---|
Stock_Tracker: Latest Orexo (ORXOF) Headlines Orexo AB announces conversion of convertible bonds int | Stock_Tracker | investorshangout | 03/11/2014 2:20:22 AM |
chartguy89: ORXOF 25.02 Stock Charts $ORXOF 1 Month Chart | chartguy89 | investorshangout | 03/09/2014 6:58:39 AM |
chartguy89: ORXOF Stock Charts Last: -0.66 Friday, February 28, 2014 at 1:49:49 PM $ORXOF 1 | chartguy89 | investorshangout | 02/28/2014 6:50:00 PM |
News, Short Squeeze, Breakout and More Instantly...
Orexo's patent win for ZUBSOLV® appealed PR Newswire UPPSALA, Sweden , July 24, 2023 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces that Sun Pharmaceutical Industries Limited, Sun Pharma Global FZE, Sun Pharma Global, Inc.,...
Orexo Q4 2020, incl. Full Year Report ZUBSOLV® stable and strong EBIT, despite challenging market due to COVID-19 PR Newswire UPPSALA, Sweden , Jan. 28, 2021 /PRNewswire/ -- Q4 2020 highlights Total net revenues of SEK 159.2 m (238.1 la...
Orexo announces new US patent for ZUBSOLV® PR Newswire UPPSALA, Sweden , Dec. 30, 2020 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the US Patent and Trademark Office has issued an additional patent for ZUBSOLV®...